Corporate Profile  

Target Market 
 

Business Strategy
Our Story

Chairman's Message

Co-Founder's Message

Mission Statement

Officers & Key Personnel

Scientific Advisory Board

 

   
CVBT Scientific Advisory Board  
 

 

CVBT's research work is led by its Scientific Advisory Board. The Board consists of some of the world's leading scientists in the fields of protein biochemistry and angiogenesis:

Ralph A. Bradshaw, Ph.D.
Chair of Scientific Advisory Board

Michael Blaber, Ph.D.
Professor of Biomedical Sciences, College of Medicine, Florida State University

Vance Gardner, M.D.
Director of Orthopaedic Education and Research Institute of Southern California

John (Jack) William Jacobs, Ph.D.
Vice President, Chief Scientific Officer and Chief Operating Officer


Thomas J. Stegmann, M.D., Ph.D.
Co-Founder, Chief Medical Officer

Kenneth A. Thomas, Ph.D.
Vice President, Research and Development

Lynne Wagoner, M.D.
Cardiologist, Greater Cincinnati Cardiovascular Consultants (GCCC)

 

 

 


 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership